🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Pharmacokinetics, Bioavailability, Safety and Immunogenicity of Single Dose...
Status
Completed
Location
Ppd Development
Start Date
2007-12
Trial ID
NCT00569803
Treatments Being Tested
Pemphigus vulgaris (PV) is a rare, chronic, debilitating, and potentially l...
Status
Unknown
Location
Tongji Hospital
Start Date
2021-02-01
Trial ID
NCT05303272
Treatments Being Tested
A randomized, controlled pilot trial to evaluate the efficacy and safety of...
Status
Completed
Location
Cedars-Sinai Medical Center
Start Date
2018-01-01
Trial ID
NCT03215927
The purpose of this study is to determine whether switching to subcutaneous...
Status
Completed
Location
Rheumatology Associates Of N. Al, P.C.
Start Date
2008-05
Trial ID
NCT00663702
Treatments Being Tested
The purpose of this study is to assess the efficacy, pharmacokinetics, safe...
Status
Completed
Location
Local Institution
Start Date
2009-12
Trial ID
NCT01001832
Treatments Being Tested
The study hypothesis is that SC abatacept is safe and shows evidence of eff...
Status
Completed
Location
Arthritis Associates of Southern California
Start Date
2014-09
Trial ID
NCT02161406
The study is a two-arm, multicenter, double-blinded clinical trial testing ...
Status
Active Not Recruiting
Location
Childrens Hospital of Orange County
Start Date
2023-10-30
Trial ID
NCT03929601
Treatments Being Tested
The hypothesis of this study is that subcutaneous Abatacept is effective in...
Status
Completed
Location
Orrin M. Troum, MD and Medical Associates
Start Date
2011-03
Trial ID
NCT01333878
Treatments Being Tested
The purpose of this study is to compare subcutaneous Abatacept to placebo i...
Status
Completed
Location
Arizona Arthritis & Rheumatology Research PLLC
Start Date
2013-06-17
Trial ID
NCT01860976
Vitiligo is a chronic autoimmune disease with evidence of CTLA-4 involvemen...
Status
Unknown
Location
Brigham and Women's Hospital
Start Date
2015-01
Trial ID
NCT02281058
Treatments Being Tested